|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,210.00 KRW | -8.26% |
|
+0.92% | -26.67% |
| 05-20 | Aprogen Medicines Inc. announced that it expects to receive KRW 10 billion in funding from N2Tech Co.,Ltd | CI |
| 25-07-24 | N2Tech Co.,Ltd announced that it has received KRW 10 billion in funding | CI |
Company Valuation: N2Tech Co.,Ltd
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 180,730 | 119,150 | 65,840 | 64,320 | 45,055 | 56,939 |
| Change | - | -34.07% | -44.74% | -2.31% | -29.95% | 26.37% |
| Enterprise Value (EV) 1 | 201,908 | 108,612 | 41,255 | 37,209 | 14,345 | 49,077 |
| Change | - | -46.21% | -62.02% | -9.81% | -61.45% | 242.11% |
| P/E | -6.15x | -2.72x | -49.1x | 5.94x | -1.76x | 2.5x |
| PBR | 3.98x | 1.98x | 0.75x | 0.58x | 0.52x | 0.45x |
| PEG | - | 0.2x | 0.5x | -0x | 0x | -0x |
| Capitalization / Revenue | 3.14x | 2.67x | 1.54x | 1.87x | 3.31x | 1.98x |
| EV / Revenue | 3.51x | 2.43x | 0.96x | 1.08x | 1.05x | 1.71x |
| EV / EBITDA | 47.3x | -35.1x | -16.3x | -35.4x | -4.82x | 4.97x |
| EV / EBIT | 121x | -14.8x | -10.7x | -19.4x | -4.07x | 5.2x |
| EV / FCF | -731x | -5.8x | 18.8x | -20.5x | 5.99x | -1.59x |
| FCF Yield | -0.14% | -17.3% | 5.32% | -4.88% | 16.7% | -63.1% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -3,685 | -3,058 | -73.16 | 522.9 | -1,235 | 660 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 57,475 | 44,629 | 42,811 | 34,306 | 13,614 | 28,764 |
| EBITDA 1 | 4,267 | -3,098 | -2,531 | -1,051 | -2,975 | 9,874 |
| EBIT 1 | 1,670 | -7,331 | -3,868 | -1,919 | -3,522 | 9,439 |
| Net income 1 | -19,532 | -33,370 | 1,533 | 10,738 | -25,570 | 18,963 |
| Net Debt 1 | 21,177 | -10,538 | -24,585 | -27,112 | -30,710 | -7,861 |
| Reference price 2 | 22,650.00 | 8,325.00 | 3,595.00 | 3,105.00 | 2,175.00 | 1,650.00 |
| Nbr of stocks (in thousands) | 7,979 | 14,312 | 18,314 | 20,715 | 20,715 | 34,508 |
| Announcement Date | 9/28/20 | 9/17/21 | 3/1/23 | 3/21/24 | 3/21/25 | 3/19/26 |
1KRW in Million2KRW
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 30.31M | |
| 49.07x | 15.01x | 38.12x | 0.56% | 690B | |
| 62.42x | 18.84x | 50.39x | 0.3% | 438B | |
| 45.74x | 10.08x | 31.59x | 1.08% | 205B | |
| 39.6x | 4.08x | 18.54x | 1.31% | 92.57B | |
| 148.44x | 45.75x | 118.1x | 0.25% | 28.95B | |
| 52.6x | 16.88x | 35.06x | 0.72% | 24.63B | |
| 56.29x | 7.28x | 25.77x | 0.28% | 22.17B | |
| 29.29x | 4.43x | 18.7x | 1.03% | 21.25B | |
| 33.71x | 2.46x | 13.41x | 0.48% | 17.47B | |
| Average | 57.46x | 13.87x | 38.85x | 0.67% | 154.07B | |
| Weighted average by Cap. | 53.44x | 14.99x | 40.29x | 0.6% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- A227950 Stock
- Valuation N2Tech Co.,Ltd
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
